Evaluation of an mHealth Intervention Designed to Increase Child Vaccination Coverage in Mozambique

How to cite

Crowley, Lucas; Fink, Gunther; Karlan, Dean. 2016. "Evaluation of an mHealth Intervention Designed to Increase Child Vaccination Coverage in Mozambique." AEA RCT Registry. AEARCTR-0001184. https://doi.org/10.1257/rct.1184-1.0

Download: BibTeX · RIS — for reference managers without a browser translator. Zotero and most others pick up this page's citation metadata directly.

Lucas Crowley* , Gunther Fink , Dean Karlan

* Primary investigator

Registry ID
AEARCTR-0001184
DOI
https://doi.org/10.1257/rct.1184-1.0
First registered
Last updated
Status
On going
Trial dates
2015-02-01 – 2019-03-01
Countries
Private
Registry record
http://www.socialscienceregistry.org/trials/1184

Abstract

Mozambique has a high child mortality rate, with a substantial portion of these deaths stemming from vaccine-preventable diseases. A key issue is the drop-off between the first and subsequent doses of a vaccine. This evaluation tests a mobile phone-based application introduced to health facility technicians in the Ministry of Health's national Extended Program of Immunization (EPI). The application is intended to (a) improve the EPI's management of vaccine stock and (b) automatically remind caregivers of upcoming vaccination appointments. The evaluation examines the impact of the intervention on child vaccination rates and management of the vaccine supply chain.

Intervention

The mVacciNation application was developed by Mezzanine, a Vodafone subsidiary, and runs on entry-level Android smartphones. As part of this intervention, one technician in the Extended Program of Immunization (EPI) of each treatment health facility will be given a smartphone equipped with the mVacciNation application. The technician will use the mVacciNation application to register caregivers and their children on a Ministry of Health database. The application will send SMS reminders of upcoming vaccination appointments to caregivers. It will also allow the EPI team to view and record vaccination events for each child. Finally, the application will prompt the EPI team to regularly report on vaccine stock levels in an effort to improve supply chain management of vaccines.

Experimental design

Eligible health facilities in Nampula Province, Mozambique, are randomly assigned to either the treatment group or the control group with equal probability. Eligibility is defined as public health facilities (a) with a GSM cellular network signal (b) that were administering child vaccines immediately prior to baseline.

Design details

Randomization method
Stata do.file.
Randomization unit
The unit of randomization is the health facility/health facility population catchment area. A health facility's catchment area is defined as the collection of census enumeration areas (EAs) for which that particular health facility is the nearest health facility, measured as the distance between the health facility and the centroid of the EA. (The shape file data set of census EAs was shared by the Institute of Statistics of Mozambique.)
Clusters
This evaluation consists of 151 experimental health facilities for health facility-level outcome measures (e.g., vaccine stock levels) in the non-clustered portion of the study. There is a sub-set of 80 experimental health facility catchment areas for caregiver- and child-level outcome measures (e.g., complete vaccination coverage rates) in the clustered portion of the study.
Observations
The clustered portion of the study consists of approximately 2,400 children aged 12 to 23 months-old.
Arms
The sample for the non-clustered portion of the study consists of 76 treatment and 75 control health facilities. The sample for the clustered portion of the study consists of a sub-set of 40 treatment and 40 control health facility catchment areas with approximately 1,200 children apiece.
Primary outcomes
The primary outcome of interest is complete coverage of the combination vaccine for diphtheria, pertussis, and tetanus ("DPT"). Other outcomes of interest include complete coverage of the Bacillus Calmette–Guérin vaccine ("BCG"), the polio vaccine, the pneumococcal conjugate vaccine ("PCV"), and the measles vaccine. The evaluation will also test the impact of the intervention on the length of intervals between vaccine doses and vaccine stock levels at the health facility level.

Cited by

No citation data available for this registration yet.

Keywords